Psychiatry and Neurology, Neurology · Alexandria, LA
NPI
1962737080
Since 2009
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
3311 Prescott Rd Ste 216
Alexandria, LA, 71301
Phone (318) 443-0490
Groups this clinician bills Medicare through
Medicare paid, 2024
$350K
9,602 services
Medicare patients, 2024
903
Average age 72
Drug cost, 2024
$3.0M
2,311 prescriptions
Company payments, 2025
$18K
From 35 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ariel O Antezana was code J0585 (injection, onabotulinumtoxina, 1 unit), 6,400 times for 16 patients. In total Ariel O Antezana billed 9,602 services in 41 codes, and Medicare paid $350K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 6,400 | 16 | $4.98 | $32K |
| 99214 Office E&M - Established | Office | 562 | 412 | $83.51 | $47K |
| 99213 Office E&M - Established | Office | 496 | 330 | $56.75 | $28K |
| 95816 Neurologic | Office | 257 | 253 | $263.33 | $68K |
| 95886 Electrical Nerve Conductivity | Office | 235 | 119 | $66.22 | $16K |
| 93886 Ultrasound - Nonspecific | Office | 189 | 189 | $182.57 | $35K |
| 99204 Office E&M - New | Office | 188 | 188 | $110.00 | $21K |
| 96137 Behavioral Health Services | Office | 175 | 172 | $26.27 | $4,598 |
| 99222 Hospital E&M - Initial | Facility | 167 | 165 | $96.36 | $16K |
| 96132 Behavioral Health Services | Office | 151 | 149 | $92.19 | $14K |
| 96136 Behavioral Health Services | Office | 150 | 149 | $29.15 | $4,372 |
| 95909 Electrical Nerve Conductivity | Office | 71 | 71 | $91.35 | $6,486 |
| 99205 Office E&M - New | Office | 67 | 67 | $146.95 | $9,845 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 66 | 66 | $117.97 | $7,786 |
| 99232 Hospital E&M - Subsequent | Facility | 63 | 45 | $58.13 | $3,662 |
By year: 2022 $305K for 6,135 services; 2023 $291K for 5,026 services; 2024 $350K for 9,602 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ariel O Antezana prescribed most often to Medicare patients was Donepezil Hcl, with 374 prescriptions and refills. In total Ariel O Antezana wrote 2,311 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Donepezil Hcl Generic | 374 | 540 | 100 | $2,339 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 180 | 251 | 52 | $2,881 |
| Amitriptyline Hcl Generic | 128 | 150 | 33 | $779 |
| Pregabalin Generic | 86 | 103 | 22 | $795 |
| Gabapentin Generic | 85 | 107 | 23 | $665 |
| Levetiracetam Generic | 82 | 128 | 17 | $1,221 |
| Memantine Hcl Generic | 74 | 120 | 18 | $1,276 |
| Carbamazepine Er Carbamazepine | 60 | 94 | 14 | $4,372 |
| Baclofen Generic | 59 | 77 | 12 | $730 |
| Ropinirole Hcl Generic | 59 | 78 | 15 | $779 |
| Lacosamide Generic | 57 | 59 | 12 | $2,165 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 53 | 53 | Under 11 | $249K |
| Quetiapine Fumarate Generic | 51 | 95 | 18 | $1,453 |
| Lamotrigine Generic | 39 | 64 | 17 | $713 |
| Phenytoin Sodium Extended Generic | 36 | 36 | Under 11 | $638 |
Brand drugs: 374 claims; generic drugs: 1,911 claims; opioid claims: 28.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ariel O Antezana $18K ($18K in general payments such as food, travel and fees) from 35 companies. The largest payer was Genzyme Corporation with $9,612.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 3 | $9,612 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $2,832 |
| Abbvie Inc. ABBV | 70 | $847 |
| EMD Serono, Inc. MRK.DE | 5 | $680 |
| Biogen, Inc. BIIB | 16 | $497 |
| UCB, Inc. UCB.BR | 16 | $355 |
| Neurocrine BioSciences, Inc. NBIX | 28 | $335 |
| TG Therapeutics, Inc. TGTX | 11 | $320 |
| ACADIA Pharmaceuticals Inc ACAD | 24 | $278 |
| Novartis Pharmaceuticals Corporation NVS | 8 | $189 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.